Golden Road Advisors LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Golden Road Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.8% in the third quarter, Holdings Channel reports. The firm owned 397 shares of the healthcare conglomerate’s stock after selling 231 shares during the quarter. Golden Road Advisors LLC’s holdings in UnitedHealth Group were worth $232,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Tealwood Asset Management Inc. purchased a new position in UnitedHealth Group in the 3rd quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV lifted its position in UnitedHealth Group by 1.2% during the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after purchasing an additional 150 shares during the period. Sequoia Financial Advisors LLC raised its stake in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after buying an additional 3,006 shares during the last quarter. Concord Investment Counsel Inc. purchased a new position in shares of UnitedHealth Group in the 1st quarter worth $14,544,000. Finally, Hennion & Walsh Asset Management Inc. increased its position in UnitedHealth Group by 14.8% during the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after acquiring an additional 1,283 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on UNH. Barclays reduced their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Royal Bank of Canada reduced their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH opened at $564.40 on Friday. The business’s 50 day simple moving average is $582.30 and its 200-day simple moving average is $540.65. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The stock has a market capitalization of $521.18 billion, a price-to-earnings ratio of 36.77, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the firm posted $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.49%. UnitedHealth Group’s payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.